News Moderna builds commercial muscle as new launches loom Moderna expands its commercial team, as the FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow.
News Hacking ring seeks to extort Novo Nordisk after cyberattack FulcrumSec has reportedly offered data from a Novo Nordisk breach for sale after a $25m ransom was rejected, but has a second breach also occurred?
News Germany said to be backtracking on pharma rebate changes Germany's government is reportedly scrapping plans to introduce a controversial system of variable rebates on medicines.
News FDA starts kicks off review of Gilead's weekly HIV pill The FDA is due to deliver a verdict in February on Gilead's once-weekly pill for HIV PrEP, which could expand the options available to patients.
News Dispensing data exposes health inequalities in England A study linking dispensing data to patient characteristics in England has exposed differences in medicine use across ethnic and socioeconomic groups.
News Poolbeg expects first data for CRS drug in the summer A trial to see if Poolbeg's POLB-001 can prevent cytokine release syndrome in multiple myeloma treated with immunotherapy Tecvayli will start soon.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.